Ayala Pharmaceuticals Inc (OP: ADXS )

0.0270 UNCHANGED
Streaming Delayed Price Updated: 3:23 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form DEFR14A
Source: SEC/Edgar
May 21, 2013
Form S-1
Source: SEC/Edgar
May 14, 2013
Form DEFA14A
Source: SEC/Edgar
May 13, 2013
Form 424B3
Source: SEC/Edgar
May 13, 2013
Form 8-K
Source: SEC/Edgar
May 07, 2013
Form DEFA14A
Source: SEC/Edgar
April 29, 2013
Form DEF 14A
Source: SEC/Edgar
April 29, 2013
Form 424B3
Source: SEC/Edgar
April 23, 2013
Form PRE 14A
Source: SEC/Edgar
April 17, 2013
Form 424B3
Source: SEC/Edgar
April 08, 2013
Form 424B3
Source: SEC/Edgar
March 25, 2013
Form 424B3
Source: SEC/Edgar
March 25, 2013
Form 10-Q/A
Source: SEC/Edgar
March 24, 2013
Form NT 10-Q
Source: SEC/Edgar
March 17, 2013
Form 8-K
Source: SEC/Edgar
March 06, 2013
Form 424B3
Source: SEC/Edgar
March 06, 2013
Form 424B3
Source: SEC/Edgar
March 06, 2013
Form 8-K
Source: SEC/Edgar
March 05, 2013
Form 424B3
Source: SEC/Edgar
March 03, 2013
Form 424B3
Source: SEC/Edgar
March 03, 2013
Form 10-K/A
Source: SEC/Edgar
February 27, 2013
Form 424B3
Source: SEC/Edgar
February 14, 2013
Form 424B3
Source: SEC/Edgar
February 14, 2013
Form 10-K/A
Source: SEC/Edgar
February 13, 2013
Form 424B3
Source: SEC/Edgar
February 11, 2013
Form NT 10-K
Source: SEC/Edgar
January 29, 2013
Form 8-K
Source: SEC/Edgar
December 27, 2012
Form SC 13G
Source: SEC/Edgar
December 20, 2012
Form 8-K
Source: SEC/Edgar
December 20, 2012
Form 424B3
Source: SEC/Edgar
December 13, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.